Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Charles Janac sold 14,180 shares of the stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $10.01, for a total transaction of $141,941.80. Following the transaction, the chief executive officer now directly owns 10,207,746 shares of the company's stock, valued at approximately $102,179,537.46. This trade represents a 0.14 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
K Charles Janac also recently made the following trade(s):
AIP stock traded down $0.39 during trading on Thursday, hitting $8.95. 183,679 shares of the company's stock were exchanged, compared to its average volume of 167,448. The business has a 50-day moving average price of $8.15 and a two-hundred day moving average price of $7.86. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $359.58 million, a price-to-earnings ratio of -9.32 and a beta of 1.25. Arteris, Inc. has a 52-week low of $4.83 and a 52-week high of $10.60.
Institutional investors and hedge funds have recently made changes to their positions in the company. US Bancorp DE acquired a new position in Arteris in the 3rd quarter valued at about $34,000. The Manufacturers Life Insurance Company acquired a new stake in Arteris during the 2nd quarter worth approximately $86,000. Algert Global LLC purchased a new position in shares of Arteris in the 2nd quarter valued at approximately $115,000. MetLife Investment Management LLC increased its holdings in shares of Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock valued at $131,000 after purchasing an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Arteris during the third quarter worth approximately $226,000. 64.36% of the stock is owned by hedge funds and other institutional investors.
Separately, Rosenblatt Securities reiterated a "buy" rating and set a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.
View Our Latest Stock Report on Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.